OPEN MINDS Shares RCPA Member Johnson & Johnson Video Series on Redefining Treatment Goals For Adults With Schizophrenia Policy AreasMental Health Oct 28, 2024 0 0
FDA Puts Restriction on Johnson & Johnson’s COVID-19 Vaccine Due to Blood Clot Risk In the NewsArticles of InterestPolicy AreasBrain InjuryChildren's ServicesCriminal JusticeIntellectual & Developmental DisabilitiesMedical RehabMental HealthPhysical Disabilities & AgingSubstance Use Disorder May 6, 2022 0 0
CDC Signs Off on Moderna and Johnson & Johnson Boosters In the NewsArticles of InterestPolicy AreasBrain InjuryChildren's ServicesCriminal JusticeIntellectual & Developmental DisabilitiesMedical RehabMental HealthPhysical Disabilities & AgingSubstance Use Disorder Oct 22, 2021 0 0 Photo by CDC on Unsplash